ReviewJournal for immunotherapy of cancer2022

Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells.

Sainiteesh Maddineni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.